
Nrhiav txoj kev kho mob cancer yog qhov tseem ceeb heev. Phau ntawv qhia no tshawb nrhiav Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy (UMIPICT), nws cov txiaj ntsig, qhov muaj peev xwm tsis zoo, thiab yuav ua li cas thiaj nrhiav tau tus kws kho mob nyob ze koj. Peb mam li npog cov txheej txheem, nws qhov tsim nyog rau cov qog nqaij hlav sib txawv, thiab yuav xav li cas thaum thiab tom qab kho. Kawm txog tus kheej nam ntawm qhov kev kho mob siab tshaj no thiab seb nws txawv li cas ntawm cov txheej txheem ib txwm muaj.
Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy yog ib qho kev kho mob qog noj ntshav uas ua ke nrog qhov tseeb ntawm kev phais me me nrog lub zog ntawm tus kheej cov tshuaj. Nws suav nrog kev txhaj tshuaj tshwj xeeb ua ke ntawm cov tshuaj khomob thiab cov tshuaj tiv thaiv kab mob ncaj qha rau hauv cov qog. Qhov kev tsom mus kom ze yog txhawm rau ua kom muaj txiaj ntsig zoo tshaj plaws ntawm kev kho mob thaum txo qis cov kev mob tshwm sim piv rau cov tshuaj siv tshuaj kho mob ib txwm muaj.
UMIPICT leverages kev nce qib hauv ob qho tib si oncology thiab kev phais mob. Ib qho kev phais me me yog tsim, tso cai rau cov kws phais kom xa cov tshuaj kho mob cocktail ncaj qha mus rau qhov chaw qog. Qhov no ua kom cov tshuaj ntau dua ntawm cov qog, txo qhov kev xav tau ntawm cov kab mob siab, yog li txo qhov cuam tshuam rau cov ntaub so ntswg noj qab haus huv. Cov tshuaj tiv thaiv kab mob tiv thaiv ntxiv txhim kho lub cev lub cev tiv thaiv kab mob tiv thaiv kab mob qog noj ntshav.
Tus kheej nam yog qhov tseem ceeb. Ua ntej yuav mus rau UMIPICT, cov neeg mob tau txais kev ntsuam xyuas dav dav, suav nrog kev tshuaj ntsuam caj ces ntawm lawv cov qog, txhawm rau txiav txim siab qhov sib xyaw ua ke zoo tshaj plaws ntawm kev siv tshuaj khomob thiab tshuaj tiv thaiv kab mob rau lawv cov mob qog noj ntshav tshwj xeeb thiab cov yam ntxwv. Qhov kev ua kom haum no ua rau kom muaj kev vam meej thiab pab txo qis kev pheej hmoo ntawm kev tawm tsam.
Cov txiaj ntsig muaj peev xwm ntawm UMIPICT suav nrog:
Nws yog ib qho tseem ceeb kom paub txog tej yam drawbacks:
Nrhiav ib tus kws kho mob tsim nyog rau Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy yuav tsum tau ua tib zoo tshawb fawb. Nrhiav cov tsev kho mob thiab cov chaw kho mob qog noj ntshav nrog lub tuam tsev kho mob oncology muaj zog thiab cov kws phais neeg mob uas muaj kev paub tshwj xeeb hauv cov txheej txheem ua kom tsawg thiab cov tshuaj kho tus kheej. Tshawb xyuas lawv lub vev xaib kom paub txog lawv cov kev paub dhau los nrog UMIPICT thiab cov ntawv pov thawj tus neeg mob. Koj tuaj yeem sab laj nrog koj tus kws kho mob thawj zaug lossis tus kws kho mob oncologist rau kev xa mus.
Thaum xaiv ib lub chaw kho mob, xav txog cov hauv qab no:
Yog xav paub ntxiv txog kev kho mob qog noj ntshav thiab kev tshawb fawb, xav txog kev tshawb nrhiav cov peev txheej xws li National Cancer Institute (https://www.cancer.gov/) thiab cov koom haum tshawb fawb txog mob qog noj ntshav. Rau cov neeg nrhiav kev xaiv hauv Suav teb, Shandong Baofa Cancer Research Institute yog ib lub tsev kawm ua thawj coj uas mob siab rau muab kev saib xyuas mob qog noj ntshav.
Disclaimer: Cov ntaub ntawv no yog rau kev kawm nkaus xwb thiab tsis yog cov lus qhia kho mob. Nco ntsoov sab laj nrog ib tus kws kho mob uas tsim nyog rau kev kuaj mob thiab kho txhua yam mob.